Skip to main content
FinSpry Logo
FinSpry
PRQR logo
PRQR
(NASDAQ)
ProQR Therapeutics N.V.
$1.79-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ProQR Therapeutics (PRQR) Stock Price & Financial Analysis

ProQR Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.74 - $1.83
52-Week High$3.10
52-Week Low$1.33
Open$1.81
Volume589.05K
Average Volume (3M)1.36M
Market Cap190.71M
Shares Outstanding105.36M
Price to Sales (P/S)11.43
Price to Book (P/B)4.09
EV/EBITDA-2.09
Revenue (TTM)15.32M
Net Income (TTM)-52.14M
Free Cash Flow (TTM)-56.37M
EPS (TTM)$-0.49
Profit Margin-339.75%
Operating Margin-345.66%
Return on Equity (ROE)-121.44%
Debt to Equity0.36
50-Day MA$1.62
200-Day MA$1.87
52-Week Change-30.42%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About ProQR Therapeutics

What is the current stock price for PRQR?

As of the latest trading session, PRQR stock trades at $1.79. The 52-week range is $1.33–$3.10, with a day range of $1.74–$1.83.

What is the P/E ratio for PRQR?

The P/E ratio (Price-to-Earnings) for PRQR is shown in the Key Statistics section. This valuation metric helps compare ProQR Therapeutics N.V. to industry peers.

Does PRQR pay dividends?

ProQR Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PRQR?

Based on 5 analysts, the consensus for PRQR is Buy.

What is the market cap of PRQR?

ProQR Therapeutics's market capitalization is $188.6M, classifying it as a micro-cap company. ProQR Therapeutics operates in the Healthcare sector within the Biotechnology industry.